logo
episode-header-image
Sep 2023
9m 22s

Moderna CEO Talks New Drugs

bloomberg

About this episode

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. 

See omnystudio.com/listener for privacy information.

Up next

Nov 19
Lightspeed Venture Partners' Sebastian Duesterhoeft Talks Investing in Anthropic
As Anthropic goes public after a historic IPO, Sebastian Duesterhoeft, Partner at Lightspeed Venture Partners, talks Anthropic's first day of trading and how it feels to be investing in the company. He spoke to Bloomberg's Carol Massar, Tim Stenovec and Ed Ludlow.See omnystudio.c ... 
11m 6s
Nov 19
Nasdaq President Nelson Griggs Talks Anthropic IPO
Nelson Griggs, president of Nasdaq, discusses how the Nasdaq has captured three of the biggest IPOs in history - SpaceX, SK Hynix and now Anthropic. He talks about the ANT listing and what to expect once shares start trading. He joins Ed Ludlow from the Nasdaq on “Bloomberg Tech. ... 
9m 35s

Recommended Episodes

Aug 2021
SEC to Demand More Transparency From China
Dr. Vino Palli, CEO of MiDoctor Urgent Care, discusses the Covid virus and vaccinations. Businessweek Technology Editor Joshua Brustein talks about his Businessweek Magazine story Afghanistan War Turns a U.S. Military Startup Into a Unicorn. Bloomberg News Financial Regulations R ... 
42m 46s
Dec 2020
Heal Chief Medical Officer on COVID-19 Vaccine Distribution
Dr. Renee Dua, Chief Medical Officer of Heal, provides a coronavirus and vaccine update. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Real Estate Reporter Patrick Clark talk about the story “Airbnb Salvaged Its IPO by Mastering the Pandemic Pivot.” Bloomberg News E ... 
33m 41s
Nov 2023
The State of EVs, Outlook for Crypto, Talent Strategies
On this edition of Bloomberg Businessweek, hosts Paul Sweeney and Matt Miller speak with Daniel Barel, CEO of REE Automotive, Chris Heller, co-founder of Cordillera Investment Partners, Nicola Hancock, Managing Director of the Americas at AMS, Vinh Vuong, CEO at Garrison Fathom a ... 
42 m
Feb 2021
Bishop T.D. Jakes on Understanding Covid-19 Vaccines
Bloomberg News Technology Reporter Matt Day discusses Amazon’s incoming CEO and his influence on the technology industry. Bishop T.D. Jakes, Chairman of the T.D. Jakes Foundation, shares thoughts on “Conversations with America: Understanding the COVID-19 Vaccine.” Bloomberg Busin ... 
41m 2s
Aug 2021
U.S. To Urge Covid-19 Booster Shots
Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ... 
35m 26s
Aug 2021
FDA Grants Full Approval of Pfizer-BioNTech Vaccine
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, discusses U.S. regulators granting full approval of the Covid-19 vaccine made by Pfzier and BioNtech, a milestone expected to help bolster the immunization drive. Bloomberg Law Health Care Reporter Shira Stein shares her story Preg ... 
36m 24s
Jan 2021
Wall St. Reviving Dream of Bitcoin ETF
Dr. Ken Redcross, Founder of Redcross Concierge, discusses Covid vaccines and communities most at risk. Bloomberg CityLab Reporter Kriston Capps talks about the story “Trump Has One Last Chance to Meddle With Census Numbers.” John Fieldly, CEO at Celsius Holdings, talks about the ... 
40m 13s
Aug 2022
Vaccine Usefulness and the Business of Bitcoin Mining
Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone discusses the usefulness of vaccines. Greg Greifeld, Deputy Chief Investment Officer at Runway Growth Capital talks about venture debt. Sam Tabar, Chief Strategy Officer at Bit Digital, discusses the business of bit ... 
27m 9s
Feb 2024
Moderna and Drug Discovery With AI
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ... 
36m 35s
Aug 2021
Noubar Afeyan
Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.See ... 
22m 42s